Technology
Who We Serve
About Us
News
Contact Us
Get a Demo
Elucent Medical Receives FDA Breakthrough Device Designation for EnVisio X1™ In-Body Spatial Intelligence™ System.
Christina Schallenkamp
May 15, 2025
Previous:
Trinity Capital Inc. Provides $30 Million in Growth Capital to Elucent Medical
Next:
Elucent Medical Marks 25,000 Lives Impacted Through EnVisio® Technology